Clinical Trial

Drug on Urinary Sodium Excretion Response to Mental Stress

Study Description

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

The purpose of this study is to determine if stopping the stress induced increase in inflammation will prevent sodium retention which in turn increases blood pressure. Each subject will test two separate times. One week, they will be taking a daily dose of mycophenolate mofetil (MMF), the other week they will be taking a placebo.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - mycophenolate mofetil (MMF)

an immunosuppressant - 500 mgs twice a day for 7 1/2 days - in capsule form

Drug - Placebo

a sugar pill - 500 mgs twice a day for 7 1/2 days - in the same capsule form as the MMF

Additional Information

Official Study Title

Comparing the Effects of an Immunosuppressant (Mycophenolate Mofetil or MMF) on the Urinary Sodium Excretion Response to Mental Stress in a Crossover Design (MMF)

Clinical Trial ID

NCT02432339

ParticipAid ID

BeXY8a